ELTP - Elite Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.092871
+0.000671 (+0.727765%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.092200
Open0.090000
Bid0.000000 x 0
Ask0.000000 x 0
Day's Range0.089000 - 0.092900
52 Week Range0.089000 - 0.250000
Volume518,124
Avg. Volume751,043
Market Cap72.6M
Beta-0.10
PE Ratio (TTM)-11.61
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Elite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q4, 2017 By the Numbers : June 16, 2017
    Capital Cube4 months ago

    Elite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q4, 2017 By the Numbers : June 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Acura Pharmaceuticals, Inc., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Pfizer Inc. and Albany Molecular Research, Inc. (MYL-US, ACUR-US, CBM-US, ACET-US, NKTR-US, PFE-US ... Read more (Read more...)

  • Elite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q3, 2017 By the Numbers : March 15, 2017
    Capital Cube7 months ago

    Elite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q3, 2017 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Pfizer Inc., Albany Molecular Research, Inc. and Akorn, Inc. (MYL-US, CBM-US, ACET-US, NKTR-US, PFE-US, AMRI-US and ... Read more (Read more...)

  • We're sorry this is all we were able to find about this topic.